Cardiomegaly medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Cardiomegaly}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Refl..." |
No edit summary |
||
| (8 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:Cardiomegaly}} | |||
{{ | {{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | ||
==Overview== | |||
[[Diuretics]] and [[ACE inhibitor]]s are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include [[preload]] and [[afterload]] reduction. | |||
==Medical Therapy== | |||
=== Acute Pharmacotherapies === | |||
[[Diuretic]]s and [[nitrates]] are administered acutely to reduce [[preload]] and [[afterload]]. | |||
== | === Chronic Pharmacotherapies === | ||
A combination of [[diuretic]]s and [[angiotensin converting enzyme]] ([[ACE]]) inhibition is currently the standard of care. [[Digoxin]] may reduce the frequency of rehospitalization, but does not improve mortality. | |||
{{ | == References == | ||
{{reflist|2}} | |||
[[Category: | [[Category:Cardiology]] | ||
[[Category:Disease]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 10:07, 9 August 2013
|
Cardiomegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiomegaly medical therapy On the Web |
|
Directions to Hospitals Treating Cardiomegaly medical therapy |
|
Risk calculators and risk factors for Cardiomegaly medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Diuretics and ACE inhibitors are standard therapy for the chronic treatment of cardiomegaly. Acute therapies include preload and afterload reduction.
Medical Therapy
Acute Pharmacotherapies
Diuretics and nitrates are administered acutely to reduce preload and afterload.
Chronic Pharmacotherapies
A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.